Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-14

FDA Approved: IPRATROPIUM BROMIDE — Original Application (Advagen Pharma Ltd)

View source ↗

Summary

FDA approves an original application for ipratropium bromide from Advagen Pharma Ltd (ANDA 219222).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)

Snippet

ORIG AP for IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)